Pierer Mobility's KTM to File for Judicial Restructuring; FY24 Loss Expected Nov. 26 MT Swiss Market Index Closes Higher; Pierer Mobility Shares Jump Nov. 22 MT Pierer Mobility Denies Talks of Red Bull Shareholder Acquiring Stake Nov. 22 MT Global markets live:...
Krystal Biotech: Blockbuster Ambitions For Topical Gene Therapy KRYSDec. 27, 20245 Comments Rating Prothena Surges After Parkinson's Drug Misses Primary Endpoint PRTADec. 22, 20241 Comment Rating Novo Nordisk Crashes On Worse Than Expected Obesity Data (Rating Upgrade) ...
Novo Nordisk: From Peak Performance To Needing A Booster Shot NVOJan. 15, 202510 Comments Rating Microvast: Is The Latest Press Release A Subtle Hint Of A Pivot To High-Growth Sectors? MVSTJan. 13, 202510 Comments Rating ZIM Integrated Shipping Services: High Dividends Amid Freight Rates Uncer...
Novo Nordisk has been slowly increasing production capacity of its highly coveted weight loss drugs. As a result, thousands of people have began treatment per week. April 10 Start investing today: 5 steps to take right now For those new to investing, getting started isn't complicated. We brea...
such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway,...
Novo Nordisk has been slowly increasing production capacity of its highly coveted weight loss drugs. As a result, thousands of people have began treatment per week. March 27 Janet Yellen walks back Biden's comments US taxpayers on hook for Baltimore bridge collapse ...
Wall Street firm Truist Securities is betting that consumers will still buy Krispy Kreme doughnuts amid the surge in weight-loss drugs like Novo Nordisk's Ozempic. May 14 Dolly Parton releases Krispy Kreme doughnut collection Dolly Parton and Krispy Kreme revealed they have collaborated on a "Dolly...
Novo Nordisk A/S -22.78% -20.74% AbbVie, Inc. -7.73% +6.65% Roche Holding AG -7.30% +9.93% Company Performance 1 Week1 Month3 Months1 Year5 Years 2.42% 3.67%−6.09%−3.98% 1.01% Sector Performance C. DISCRETIONARYC. STAPLESENERGYFINANCIALHEALTH CAREINDUSTRIALTECHNOLOGYMATERIALSREAL ESTATE...
Novo Nordisk: CagriSema Underwhelms In REDEFINE-1 Trial NVONONOFDec. 20, 202411 Comments Rating Zymeworks: Prime Time For Ziihera, Early-Stage Pipeline Progressing Ahead Of Schedule ZYMEZYME:CADec. 19, 20244 Comments Rating Viridian Therapeutics: Veligrotug De-Risked In TED With Hints Of Differe...
Novo Nordisk: CagriSema Underwhelms In REDEFINE-1 Trial Trending Analysis AbbVie Q4 Earnings: Good 2025 Outlook Despite Enhanced Old And New Headwinds ABBVABBV:CAJan. 31, 20251 Comment AbbVie: Q4 2024 Earnings Preview And Update On Emraclidine ABBVABBV:CAJan. 26, 202514 Comments TG Therapeutics...